Search the Newsreel

Understanding Momentum Shifts in (ATRA)

The article analyzes momentum shifts for Atara Biotherapeutics Inc. (NASDAQ: ATRA), highlighting a near-term strong sentiment potentially challenging persistent mid and long-term weakness. It identifies a mid-channel oscillation pattern and an exceptional 233.0:1 risk-reward setup targeting a 69.2% gain versus 0.3% risk. The report …

ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Atara Biotherapeutics, Inc. (NASDAQ:ATRA) on behalf of investors who purchased securities between May 20, 2024, and January 9, 2026. The lawsuit alleges that Atara made false or misleading statements regarding manufacturing issues …

Atara Biotherapeutics (ATRA) Projected to Release Earnings on Monday

Atara Biotherapeutics (ATRA) is expected to release its Q2 2026 earnings before market open on Monday, August 10th, with analysts projecting a loss of $0.315 per share and revenue of $0.55 million. The company's prior quarter results showed a narrower loss than estimated but …

Cantor Fitzgerald raises Dynatrace stock price target to $47 on cloud trends

Cantor Fitzgerald raised its price target for Dynatrace Inc. (NYSE:DT) to $47 from $37, maintaining a Neutral rating, citing benefits from hybrid-cloud modernization and renewal tailwinds, alongside robust growth in its Logs consumption business. The firm also highlighted Dynatrace's undervalued stock, recent engagement with …

ETFs Investing in Dynatrace, Inc. Stocks

This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold stocks of Dynatrace, Inc. (DT). The table includes detailed financial information for each ETF, such as market value, weight of DT stock, issuer, management style, expense ratio, assets under management (AUM), …

Dynatrace, Inc. $DT Position Reduced by Glenmede Trust Co. NA

Glenmede Trust Co. NA reduced its stake in Dynatrace, Inc. by 12.1% in the first quarter, selling 79,278 shares but still retaining a significant holding worth $21.3 million. Despite this reduction, institutional investors collectively own 94.28% of the company. Dynatrace reported strong financial results …

ETFs Investing in Atara Biotherapeutics Inc Stocks

This article lists ETFs that hold stocks of Atara Biotherapeutics Inc. It highlights that these ETFs offer more accessible investment opportunities with lower risk. One specific ETF, the BUSM EA Bridgeway Ultra-Small Company Market ETF, is detailed with its market value, weight in Atara …

Dynatrace Inc (DT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Dynatrace Inc (DT), noting its current valuation score of 5.44, which ranks it 410 out of 485 in the Software & IT Services industry. The company's P/E ratio is currently 81.76, significantly below its recent high but …

MongoDB, Snowflake, Dynatrace, Domo, and AppLovin Shares Skyrocket, What You Need To Know

Shares of MongoDB, Snowflake, Dynatrace, Domo, and AppLovin jumped in pre-market trading following strong earnings reports from industry leaders like Microsoft, which indicated resilient growth in the tech sector. The positive sentiment was further supported by robust revenue increases from companies like PTC Inc., …

Dynatrace, Inc. $DT Shares Sold by Public Employees Retirement System of Ohio

The Public Employees Retirement System of Ohio significantly reduced its stake in Dynatrace, Inc. ($DT) by 54.5% during the first quarter, selling over 103,000 shares. Despite this, other institutional investors either initiated new positions or increased their holdings in Dynatrace. Wall Street analysts generally …

Amundi Grows Stock Holdings in Dynatrace, Inc. $DT

Amundi increased its stake in Dynatrace, Inc. (NYSE:DT) by 461.5% in the first quarter, now owning 6,238,938 shares valued at $230.716 million. Several other institutional investors also adjusted their positions in Dynatrace. Analyst ratings for Dynatrace are predominantly "Buy" or "Strong Buy," with an …

Dynatrace Number of Employees 2026 | Employee Count & Headcount Data

As of March 2026, Dynatrace (DT) has approximately 5,616 employees worldwide, representing a 27.9% growth since 2023. The company is actively hiring, with 313 job postings in 2026, though this is a decline from previous years. Dynatrace's workforce is primarily located in the United …

Dynatrace, Inc. Revenue Breakdown – HAM:7DY

Dynatrace, Inc. (HAM:7DY) generated €1.75 billion in revenue last year, with its Subscription segment contributing the most at €1.67 billion. The United States was the largest regional contributor, accounting for €802.95 million. This financial breakdown offers insights into the company's key performance areas.

Dynatrace (NYSE: DT) awards 10,522 RSUs to board member Thota Chandrasekhar

Dynatrace (NYSE: DT) has granted 10,522 Restricted Stock Units (RSUs) to its board member Thota Chandrasekhar. These RSUs, which represent a contingent right to receive one share of common stock each, were awarded under the company's 2019 Equity Incentive Plan and vest over several …

Dynatrace, Inc. (NYSE: DT) director Thota Chandrasekhar files initial ownership statement

Dynatrace, Inc. director Thota Chandrasekhar has filed an initial statement of beneficial ownership (Form 3) with the SEC. The filing indicates he is a director but reports no equity transactions or current holdings in company securities. It also includes an Exhibit 24 Power of …

How Dynatrace Inc. (DT) Affects Rotational Strategy Timing

This article analyzes Dynatrace Inc. (DT) and its impact on rotational strategy timing, noting strong near-term sentiment challenging persistent mid and long-term weakness. It provides institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for support and …

Dynatrace Appoints AI and Technology Leader Chandu Thota to its Board of Directors

Dynatrace (NYSE: DT) has appointed Chandu Thota, an AI and technology leader with over 20 years of experience from companies like Google and Microsoft, to its Board of Directors, effective July 27, 2026. Thota, currently Vice President of Engineering at Google Workspace, brings deep …

Dynatrace appoints Chandu Thota as Class II director

Dynatrace has appointed Chandu Thota as a Class II director, effective July 27, 2026, expanding its board from 10 to 11 members. His appointment was based on the Nominating and Corporate Governance Committee's recommendation, and he has been deemed an independent director under NYSE …

Quantinno Capital Management LP Raises Stake in Dynatrace, Inc. $DT

Quantinno Capital Management LP significantly increased its stake in Dynatrace, Inc. by 75.8% in the first quarter, now owning 1.99 million shares valued at approximately $73.6 million. Institutional investors hold a substantial 94.28% of the stock. Despite a generally positive "Moderate Buy" consensus from …

Atara Biotherapeutics Inc (ATRA) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Atara Biotherapeutics Inc (ATRA), detailing its current risk assessment score, beta value, and various volatility and financial metrics. ATRA has a risk score of 2.51, ranking 210 out of 385 in its industry, and a beta of …

Gremlin Launches Native App for Dynatrace, Adding Resilience Testing and Reliability Scoring to the Observability Platform

New app lets engineering teams run Gremlin resilience tests and surface forward-looking reliability scores directly within Dynatrace using the metrics and alerts they already trust. SAN FRANCISCO, July 28, 2026 /PRNewswire/ -- Gremlin, the reliability management platform trusted by the world's largest enterprises, today …

ATRA|Atara Biotherapeutics Inc|Price:7.680|Chg%:-0.130

This article provides a comprehensive stock analysis of Atara Biotherapeutics Inc (ATRA) by TradingKey, highlighting its "fairly valued" status within the Biotechnology & Medical Research industry and significant growth potential. The company's fundamentals are stable, with high institutional ownership and multiple "Buy" ratings from …

1,054,267 Shares in Dynatrace, Inc. $DT Acquired by American Capital Management Inc.

American Capital Management Inc. acquired a new stake of 1,054,267 shares in Dynatrace, Inc. ($DT) during the first quarter, valued at approximately $38.99 million. This investment represents about 2.1% of American Capital Management Inc.'s portfolio, making Dynatrace its 20th largest holding. The article also …

Atara Biotherapeutics Inc (ATRA) Valuation: PE, PB & Fair Value Analysis

Atara Biotherapeutics Inc (ATRA) currently holds a valuation score of 7.36, ranking 225th out of 385 companies in the Biotechnology & Medical Research industry. Its P/E ratio is -5.53, significantly below its recent high and above its recent low. Key valuation metrics like P/B, …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Atara Biotherapeutics, Inc. (ATRA) for potential corporate wrongdoing. The firm is encouraging shareholders who purchased Atara securities before May 20, 2024, and still hold them, to join the investigation. The investigation aims to recover …

Atara Biotherapeutics Inc (ATRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides an overview of Atara Biotherapeutics Inc (ATRA), including its current stock price and market capitalization. It highlights that detailed revenue breakdown data by business segment and region have not been disclosed by the company. The page serves as a …

SNX vs. DT: Which Stock Is the Better Value Option?

Investors interested in Computers - IT Services stocks are likely familiar with TD SYNNEX (SNX) and Dynatrace (DT). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. We have …

YTRA|Yatra Online Inc|Price:0.870|Chg%:+0.020

Atara Biotherapeutics Inc (ATRA) Financial Health: Profitability & Balance Sheet Analysis

Atara Biotherapeutics Inc (ATRA) has a weak financial status with a current financial score of 5.52, ranking low in the Biotechnology & Medical Research industry. The company's latest quarterly revenue decreased by 99.47% year-over-year, and its net profit decreased by 110.91% year-over-year. Several key …

Dynatrace Inc (DT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on Dynatrace Inc (DT) stock, including its current market price, market capitalization, and P/E ratio. It specifically notes that Dynatrace has distributed $0.00 in dividends over the past five years, indicating no historical dividend payouts for the company. The page …

Dynatrace's Two Investor Conference Webcasts Archived for 30 Days

Dynatrace announced that its executives will present at two upcoming investor conferences: the KeyBanc Capital Markets Technology Leadership Forum on August 10 and the Goldman Sachs Communacopia & Technology Conference on September 9. Webcasts of both presentations will be available on the company's investor …

Dynatrace Brings Autonomous Operations to Enterprise AI, Moving from Insight to Action

Dynatrace has introduced major advancements to its Intelligence platform, enabling autonomous operations for enterprise AI. These innovations, including new autonomous SRE agents and custom agent creation capabilities, help resolve incidents, prevent disruptions, and accelerate operations by grounding AI actions in deterministic, real-time understanding rather …

Dynatrace to Present at Upcoming Investor Conferences

Dynatrace (NYSE: DT) announced that its executives will present at two upcoming investor conferences: the KeyBanc Capital Markets Technology Leadership Forum on August 10 and the Goldman Sachs Communacopia & Technology Conference on September 9. Webcasts of these presentations will be available on the …

Dynatrace Inc (DT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Dynatrace Inc (DT), listing major institutional holders and their respective proportions. It also categorizes shareholder types and provides historical institutional shareholding data and recent shareholder activity. Additionally, the article lists various ETFs that hold Dynatrace stock.

KBC Group NV Has $411,000 Stock Position in Dynatrace, Inc. $DT

KBC Group NV significantly reduced its stake in Dynatrace, Inc. by 70.2% in the first quarter, now holding 11,112 shares valued at approximately $411,000. Despite this reduction, Dynatrace reported strong quarterly earnings, beating analyst expectations with $0.41 EPS on $531.72 million in revenue, a …

Dynatrace Inc (DT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Dynatrace Inc (DT) has an earnings forecast score of 7.89, placing it 198th in the Software & IT Services industry. The average analyst price target for DT is $63.10, with most analysts recommending a "Buy". The company's expected revenue for the next quarter is …